OBJECTIVE: To define the expressions of @entity876 , @entity588 , and @entity1262 and prognostic impact in @entity1 with @entity3191 ( @entity3191 ). MATERIAL AND METHOD: Adult @entity1 with newly diagnosed as @entity3191 were reviewedfrom 2001 to 2012. Clinical parameters and outcome data were extracted The specimens were stained for @entity876 , @entity588 , and @entity1262 . The results were analyzed for association with disease stage, International Prognostic Index (IPI), @entity784 ( @entity784 ), overall response rate (ORR), and @entity1349 ( @entity1349 ). RESULTS: Of eligible 159 @entity1 (113 males, 46 females), median age was 53 years old The histological subtypes included @entity3191 , not otherwise specified ( @entity3191 , NOS) 35.8%, angioimmunoblastic @entity784 (AITL) 18.2%, extranodal NK/ @entity784 (ENKL) 17.0%, @entity40934 ( @entity40934 ) 12.6%, @entity784 ( @entity784 ) 11.3%, @entity2108 ( @entity2108 ) 4.4%, and @entity7017 -associated @entity784 (EATL) 0.6%. Tissue samples were obtainedfor analysis in 135 @entity1 . @entity876 , @entity588 , and @entity1262 were positive in 87%, 49%, and 28%, respectively. Median @entity1349 was 25 months. The expressions of @entity876 , @entity588 , and @entity1262 were not significantly correlated with advanced stage, high prognostic scores, ORR, and @entity1349 . However @entity588 expression was statistically associated with histological subtypes. From Cox regression analyses, advanced stage, high prognostic scores, and histological subtypes were independent prognostic factors for @entity1349 . CONCLUSION: The biomarker expressions varied in different types of @entity3191 and did not show any correlation with prognostic factors, ORR, or @entity1349 .

The Expressions of @entity876 , @entity588 , and XXXX and Prognostic Impact in @entity1 with @entity3191 ( @entity3191 ).

@entity1 :: ('9606', 'Species') :: ['patients'] @entity1262 :: ('5243', 'Gene') :: ['p-glycoprotein'] @entity588 :: ('596', 'Gene') :: ['Bcl-2'] @entity3191 :: ('MESH:D016411', 'Disease') :: ['PTCL', 'peripheral T-cell lymphoma'] @entity784 :: ('MESH:D016399', 'Disease') :: ['Prognostic Index for T-cell lymphoma', 'CTCL', 'T-cell lymphoma', 'cutaneous T-cell lymphoma', 'PIT'] @entity40934 :: ('MESH:C537503', 'Disease') :: ['subcutaneous panniculitis-like T-cell lymphoma', 'SPTCL'] @entity7017 :: ('MESH:C538273', 'Disease') :: ['enteropathy'] @entity876 :: ('7157', 'Gene') :: ['P53', 'p53'] @entity2108 :: ('MESH:D017728', 'Disease') :: ['anaplastic large cell lymphoma', 'ALCL'] @entity1349 :: ('MESH:D011475', 'Disease') :: ['OS', 'overall survival']
@entity1262 :: (5243,Gene) :: ['P-Glycoprotein']
